Literature DB >> 30840605

ACG Clinical Guideline: Ulcerative Colitis in Adults.

David T Rubin1, Ashwin N Ananthakrishnan2, Corey A Siegel3, Bryan G Sauer4, Millie D Long5.   

Abstract

Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of significant clinical merit, "key concept" statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30840605     DOI: 10.14309/ajg.0000000000000152

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  253 in total

1.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

2.  Endoscopic Management of Complex Lesions in Patients With Inflammatory Bowel Disease.

Authors:  Anna M Buchner
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-03

3.  Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.

Authors:  Sara Lewin; Fernando S Velayos
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

4.  A Practical Clinical Approach to the Management of High-Risk Ulcerative Colitis.

Authors:  David T Rubin; Cindy Traboulsi; Victoria Rai
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-02

Review 5.  Is tofacitinib a game-changing drug for ulcerative colitis?

Authors:  Fernando Magro; Maria Manuela Estevinho
Journal:  United European Gastroenterol J       Date:  2020-06-18       Impact factor: 4.623

6.  Follow-Up of Patients With Ulcerative Colitis and Histological Normalization.

Authors:  Amanda Israel; Britt Christensen; Katia El Jurdi; Victoria Rai; Jacob E Ollech; Russell D Cohen; Atsushi Sakuraba; Sushila R Dalal; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-20       Impact factor: 11.382

7.  Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

Authors:  Evelyne Dubois; Annick Moens; Rob Geelen; João Sabino; Marc Ferrante; Séverine Vermeire
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

Review 8.  Popular Diet Trends for Inflammatory Bowel Diseases: Claims and Evidence.

Authors:  Andrew T Weber; Neha D Shah; Jenny Sauk; Berkeley N Limketkai
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 9.  IBD in the Elderly: Management Challenges and Therapeutic Considerations.

Authors:  Vivy Tran; Berkeley N Limketkai; Jenny S Sauk
Journal:  Curr Gastroenterol Rep       Date:  2019-11-27

Review 10.  Maneuvering Clinical Pathways for Ulcerative Colitis.

Authors:  Christopher M Johnson; Catherine D Linzay; Themistocles Dassopoulos
Journal:  Curr Gastroenterol Rep       Date:  2019-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.